Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Oxytocin in Alcohol Withdrawal
NCT03339024Phase 3Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Nov 2017
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
A Phase 3 trial of oxytocin nasal spray in alcohol dependence, alcohol withdrawal syndrome (AWS), sponsored by Norwegian University of Science and Technology. Started Nov 2017; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
alcohol dependencealcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT03339024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03339024.